Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricombi: Drug Combinations for Hookworm in Lao Children
NCT03278431Phase 4Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of oxantel in hookworm infection (4 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rates of three drug combinations. Started Sep 2017; status: completed.
02
Drugs
oxantel
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NCT03278431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03278431.